Cargando…

Third‐line therapy for overactive bladder in the elderly: Nuances and considerations

INTRODUCTION: Overactive bladder (OAB) disproportionally affects older adults in both incidence and severity. OAB pharmacotherapy is often problematic in the elderly due to polypharmacy, adverse side effect profiles and contraindications in the setting of multiple comorbidities, and concerns regardi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zillioux, Jacqueline, Slopnick, Emily A., Vasavada, Sandip P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	SPECIAL SECTION: Complex OAB Patients
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796112/ https://www.ncbi.nlm.nih.gov/pubmed/35645033 http://dx.doi.org/10.1002/nau.24965

Ejemplares similares

Complex patients – an academism or reality?
por: Džakula, Aleksandar, et al.
Publicado: (2023)

From fragmented care back to social medicine: European policy responses to the needs of complex patients
por: Džakula, Aleksandar, et al.
Publicado: (2023)

Polypharmacy - is there a cure for drug therapy problems?
por: Orehovački, Helena, et al.
Publicado: (2023)

Fragmentation, dehumanization, commodification: crisis of medicine
por: Džakula, Aleksandar, et al.
Publicado: (2023)

Hospitalists: the missing link in complex patient care
por: Džakula, Aleksandar, et al.
Publicado: (2023)

Vaginal laser for overactive bladder syndrome
por: Charalampous, Ioannis, et al.
Publicado: (2020)

Predictors of prolonged admission after outpatient female pelvic reconstructive surgery
por: Simi, Andrea M., et al.
Publicado: (2022)

Overactive bladder in the vulnerable elderly
por: Wolff, Gillian F, et al.
Publicado: (2014)

Patient and Clinician Challenges with Anticholinergic Step Therapy in the Treatment of Overactive Bladder: A Narrative Review
por: Dmochowski, Roger R., et al.
Publicado: (2023)

Health Resource Utilization and Cost for Patients with Incontinent Overactive Bladder Treated with Anticholinergics
por: Yehoshua, Alon, et al.
Publicado: (2016)

Assessing comprehension of online information in the United States for third-line treatment of overactive bladder
por: Werner, Zachary, et al.
Publicado: (2022)

Robot-assisted vesico-vaginal fistula repair: technical nuances
por: Antonelli, Alessandro, et al.
Publicado: (2020)

Update on the management of overactive bladder: patient considerations and adherence
por: Gomelsky, Alex, et al.
Publicado: (2010)

Telemedicine in Overactive Bladder Syndrome
por: Jericevic, Dora, et al.
Publicado: (2023)

Conceptual and practical foundations of patient engagement in research at the patient-centered outcomes research institute
por: Frank, Lori, et al.
Publicado: (2015)

Low-income minority patient engagement with automated telephonic depression assessment and impact on health outcomes
por: Vidyanti, Irene, et al.
Publicado: (2014)

Social, economic, and health utility considerations in the treatment of overactive bladder
por: Sacco, Emilio, et al.
Publicado: (2010)

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

Practical points in the medical treatment of overactive bladder and nocturia in the elderly
por: Chen, Jing-Liang, et al.
Publicado: (2016)

Expanded Access Programs: Ethical and Practical Considerations for Biopharmaceutical Sponsors
por: Klopfenstein, Mitchell, et al.
Publicado: (2015)

Drug information update. Atypical antipsychotics and neuroleptic malignant syndrome: nuances and pragmatics of the association
por: Sarkar, Siddharth, et al.
Publicado: (2017)

Postmenopausal overactive bladder
por: Tomaszewski, Jacek
Publicado: (2014)

Supporting the Accommodation of Voluntary and Involuntary Migrants: Humanitarian and Host Society Considerations
por: Verkuyten, Maykel, et al.
Publicado: (2018)

Effects of COVID-19 on Sense of Smell: Human Factors/Ergonomics Considerations
por: Cameron, E. Leslie, et al.
Publicado: (2021)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
por: Ulahannan, Danny, et al.
Publicado: (2009)

Mirabegron in the Treatment of Overactive Bladder: Safety and Efficacy in the Very Elderly Patient
por: Makhani, Asad, et al.
Publicado: (2020)

CORONARY CONSIDERATIONS FOR THROMBOSIS IN COVID-19 NSTEMI
por: Wilbanks, David, et al.
Publicado: (2022)

Pharmacologic management of overactive bladder
por: Lam, Sum, et al.
Publicado: (2007)

Medical management of overactive bladder
por: Ubee, Sarvpreet S., et al.
Publicado: (2010)

Urinary biomarkers of overactive bladder
por: Tian, Xiao-Jun, et al.
Publicado: (2019)

Review of the epidemiology of overactive bladder
por: Eapen, Renu S, et al.
Publicado: (2016)

Impact of depression on overactive bladder
por: Kawahara, Takashi, et al.
Publicado: (2020)

Current pharmacotherapy of overactive bladder
por: Kreydin, Evgenyi I., et al.
Publicado: (2021)

Update on the management of overactive bladder
por: Fontaine, Christina, et al.
Publicado: (2021)

Mediterranean Diet and Overactive Bladder
por: Bozkurt, Yunus Erol, et al.
Publicado: (2022)

Updates of Overactive Bladder in Pediatrics
por: Shim, Jisung, et al.
Publicado: (2023)

Urodynamic and Bladder Diary Factors Predict Overactive Bladder-wet in Women: A Comparison With Overactive Bladder-dry
por: Hsiao, Sheng-Mou, et al.
Publicado: (2019)

Efficacy of interferential low frequency therapy for elderly wet overactive bladder patients
por: Oh-oka, Hitoshi
Publicado: (2008)

Third-party reproductive practices: legislative inertia and the need for nuanced empirical data
por: Markens, Susan
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s7s2b3bugjmfu1lonb6o3uvh31